Bionime Corp
TWSE:4737

Watchlist Manager
Bionime Corp Logo
Bionime Corp
TWSE:4737
Watchlist
Price: 68.9 TWD 0.44% Market Closed
Market Cap: NT$5.3B

Bionime Corp
Other Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Bionime Corp
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Items CAGR 3Y CAGR 5Y CAGR 10Y
Bionime Corp
TWSE:4737
Other Items
NT$4.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Medimaging Integrated Solution Inc
TWSE:6796
Other Items
NT$131.8m
CAGR 3-Years
129%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Apex Biotechnology Corp
TWSE:1733
Other Items
NT$6.3m
CAGR 3-Years
N/A
CAGR 5-Years
-39%
CAGR 10-Years
-18%
Wellell Inc
TWSE:4106
Other Items
NT$49.2m
CAGR 3-Years
80%
CAGR 5-Years
-31%
CAGR 10-Years
5%
Applied BioCode Corp
TWSE:6598
Other Items
NT$136.4m
CAGR 3-Years
N/A
CAGR 5-Years
4%
CAGR 10-Years
N/A
No Stocks Found

Bionime Corp
Glance View

Market Cap
5.3B TWD
Industry
Health Care

Bionime Corp. engages in the manufacturing and selling of medical instruments, providing biotechnology services, examining pharmaceuticals, and selling precision instruments. The company is headquartered in Taichung, Taichung. The company went IPO on 2009-08-26. The firm's main products include blood glucose monitoring devices and blood glucose testing chips. Its products are applied in the testing and monitoring of blood glucose density. The firm distributes its products mainly to overseas markets, including Europe, Asia, the Americas and others.

Intrinsic Value
30.02 TWD
Overvaluation 56%
Intrinsic Value
Price NT$68.9

See Also

What is Bionime Corp's Other Items?
Other Items
4.9m TWD

Based on the financial report for Sep 30, 2025, Bionime Corp's Other Items amounts to 4.9m TWD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett